课题基金 / 基金详情

Modulating Inflammatory and Fibrogenic Pathways in Kidney Disease using a novel antagonist of Protease-Activated-Receptor-2

Modulating Inflammatory and Fibrogenic Pathways in Kidney Disease using a novel antagonist of Protease-Activated-Receptor-2
使用蛋白酶激活受体 2 的新型拮抗剂调节肾脏疾病的炎症和纤维化途径
批准号:
nhmrc : GNT1083131
负责人:
A/Pr David Nikolic-Paterson
金额:
$38.75万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2015
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2015-01-01 至 2017-12-31

项目摘要

项目成果

A/Pr David Nikolic-Paterson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Chronic kidney disease (CKD) now affects 10% of adults in industrialised countries. Current treatments are largely ineffective. Thus developing better CKD treatments will have substantial public health benefit. Three well established and clinically relevant animal models of kidney disease will be used to test the ability of a new experimental anti-inflammatory drug, developed by members of this research team at The University of Queensland, to prevent or lessen the progression of CKD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TGF-beta/Smad signalling in macrophage-mediated renal fibrosis.
  • 批准号:
    nhmrc : 1122073
  • 项目类别:
    Project Grants
  • 资助金额:
    $46.66万
  • 财政年份:
    2017
  • 负责人:
    A/Pr David Nikolic-Paterson
  • 依托单位:
Defining the central role of podocyte depletion in the development, progression and management of glomerular disease
  • 批准号:
    nhmrc : GNT1121793
  • 项目类别:
    Project Grants
  • 资助金额:
    $69.09万
  • 财政年份:
    2017
  • 负责人:
    A/Pr David Nikolic-Paterson
  • 依托单位:
Defining the central role of podocyte depletion in the development, progression and management of glomerular disease
  • 批准号:
    nhmrc : 1121793
  • 项目类别:
    Project Grants
  • 资助金额:
    $47.17万
  • 财政年份:
    2017
  • 负责人:
    A/Pr David Nikolic-Paterson
  • 依托单位:
TGF-beta/Smad signalling in macrophage-mediated renal fibrosis.
  • 批准号:
    nhmrc : GNT1122073
  • 项目类别:
    Project Grants
  • 资助金额:
    $68.37万
  • 财政年份:
    2017
  • 负责人:
    A/Pr David Nikolic-Paterson
  • 依托单位:
海外基金